Analysts Set The Beauty Health Company (NASDAQ:SKIN) Price Target at $2.32

The Beauty Health Company (NASDAQ:SKIN) has earned a consensus rating of “Hold” from the eight ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $2.32.

A number of equities analysts recently issued reports on SKIN shares. TD Cowen lowered their price target on Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a report on Monday, March 16th. Canaccord Genuity Group lowered their price objective on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a report on Friday, March 13th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $1.60 price objective on shares of Beauty Health in a report on Wednesday, January 14th. Finally, Zacks Research raised Beauty Health from a “strong sell” rating to a “hold” rating in a report on Monday, March 16th.

Institutional Investors Weigh In On Beauty Health

Institutional investors have recently added to or reduced their stakes in the business. Mirabella Financial Services LLP boosted its holdings in Beauty Health by 21.3% in the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock valued at $31,037,000 after purchasing an additional 2,734,728 shares in the last quarter. Hillsdale Investment Management Inc. purchased a new stake in Beauty Health in the 3rd quarter valued at approximately $293,000. Caprock Group LLC purchased a new stake in Beauty Health in the 3rd quarter valued at approximately $62,000. Kapitalo Investimentos Ltda boosted its holdings in Beauty Health by 45.1% in the 3rd quarter. Kapitalo Investimentos Ltda now owns 45,787 shares of the company’s stock valued at $91,000 after purchasing an additional 14,240 shares in the last quarter. Finally, Franklin Resources Inc. purchased a new stake in Beauty Health in the 3rd quarter valued at approximately $31,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Performance

NASDAQ SKIN opened at $0.65 on Wednesday. The company has a quick ratio of 1.48, a current ratio of 1.79 and a debt-to-equity ratio of 4.37. Beauty Health has a 52-week low of $0.55 and a 52-week high of $2.69. The business’s 50-day moving average price is $0.96 and its 200 day moving average price is $1.22. The firm has a market cap of $83.64 million, a P/E ratio of -3.85 and a beta of 1.12.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.04. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%.The firm had revenue of $64.91 million for the quarter, compared to analyst estimates of $66.28 million. On average, equities research analysts expect that Beauty Health will post -0.17 earnings per share for the current year.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.